NOVOZYMES BIOINDUSTRIAL A/S: Financial statements 2017
CVR: 24257908
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NOVOZYMES BIOINDUSTRIAL A/S (CVR 24257908) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -74,165 and a net result of DKK -5,390,460 compared with DKK 254,382 the year before. Equity in the 2017 report amounted to DKK 1,168,538. The solvency ratio was 4.3%.
- Gross Profit
- DKK -74,165
- Profit/Loss
- DKK -5,390,460
- Equity
- DKK 1,168,538
- Total Assets
- DKK 27,351,425
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -74K | -5.4M | 1.2M | - |
| 2016 | - | -78K | 254K | 6.6M | - |
| 2015 | - | -948K | -1.3M | 6.3M | - |
Official annual report
Keep an eye on NOVOZYMES BIOINDUSTRIAL A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of August 10, 2017, Tina Sejersgård Fanø has joined the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
As of August 10, 2017, Benny Dalgaard Loft has left the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
NOVOZYMES BIOINDUSTRIAL A/S has published its annual report for 2016. Gross profit came to DKK -77,546, and the net result was DKK 254,382.
About NOVOZYMES BIOINDUSTRIAL A/S
NOVOZYMES BIOINDUSTRIAL A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL A/S and NOVO ENZYM A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057.